The Availability of the Enhanced Liver Fibrosis (ELF) Test Affects the Rate of Diagnosis of Nonalcoholic Steatohepatitis (NASH) With Fibrosis in Patients Referred to Hepatology
Clinical trial NCT05370053 · COMPLETED
Trial details
- NCT number
- NCT05370053
- Sponsor
- University of Kansas Medical Center
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-01
- Primary completion
- 2022-12-01
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.